See the DrugPatentWatch profile for advil

After conducting a thorough analysis, it appears that Advil's market share growth can be attributed to several key factors. First, the expiration of key patents for competing drugs created an opportunity for Advil to gain a larger share of the market [1]. This allowed the makers of Advil to produce and market a generic version of the drug, which is often less expensive for consumers and can drive up sales [1].

Additionally, Advil has been proactive in expanding its product line to include new forms of the drug, such as Advil Film Coated, which dissolves quickly and is easy to swallow [2]. This has helped the company to attract new customers and retain existing ones.

Furthermore, Advil has invested heavily in marketing and advertising campaigns, which have helped to increase brand awareness and drive sales [3]. These campaigns have highlighted the effectiveness of Advil in relieving pain and have positioned the drug as a trusted and reliable option for consumers.

In conclusion, the growth in Advil's market share can be attributed to a combination of factors, including the expiration of key patents, the expansion of the product line, and strategic marketing and advertising campaigns.

Sources:
[1] "Advil." DrugPatentWatch.com, <https://www.drugpatentwatch.com/drugs/advil>.
[2] "Advil Film Coated." Advil, <https://www.advil.com/products/advil-film-coated>.
[3] "Advil TV Commercial, 'Advil: Fast, Powerful Relief' Featuring Drew Brees." iSpot.tv, 2021, <https://www.ispot.tv/ad/wzYw/advil-advil-fast-powerful-relief-featuring-drew-brees>.